心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2021 心衰专家共识：优化射血分数降低心力衰竭改善预后的药物

2021-08-27 国外心血管相关专家小组（统称） Portuguese Journal of Cardiology

射血分数降低心力衰竭

射血分数降低（HFrEF）的心力衰竭（HF）与高住院率和死亡率相关。近年来，出现了新的HFrEF改善预后的药物。本文主要针对优化改善HFrEF预后药物的应用提供共识指导。

中文标题：

2021 心衰专家共识：优化射血分数降低心力衰竭改善预后的药物

英文标题：

Optimization of heart failure with reduced ejection fraction prognosis-modifying drugs: A 2021 heart failure expert consensus paper

发布机构：

国外心血管相关专家小组（统称）

发布日期：

2021-08-27

简要介绍：

射血分数降低（HFrEF）的心力衰竭（HF）与高住院率和死亡率相关。近年来，出现了新的HFrEF改善预后的药物。本文主要针对优化改善HFrEF预后药物的应用提供共识指导。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021心衰专家共识：优化射血分数降低心力衰竭改善预后的药物.pdf)] GetToolGuiderByIdResponse(projectId=1, id=650e71c002182392, title=2021 心衰专家共识：优化射血分数降低心力衰竭改善预后的药物, enTitle=Optimization of heart failure with reduced ejection fraction prognosis-modifying drugs: A 2021 heart failure expert consensus paper, guiderFrom=Portuguese Journal of Cardiology, authorId=0, author=, summary=射血分数降低（HFrEF）的心力衰竭（HF）与高住院率和死亡率相关。近年来，出现了新的HFrEF改善预后的药物。本文主要针对优化改善HFrEF预后药物的应用提供共识指导。, cover=https://img.medsci.cn/2021910/1631279751654_5579292.jpg, journalId=0, articlesId=null, associationId=738, associationName=国外心血管相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Fri Aug 27 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>射血分数降低（HFrEF）的心力衰竭（HF）与高住院率和死亡率相关。近年来，出现了新的HFrEF改善预后的药物。本文主要针对优化改善HFrEF预后药物的应用提供共识指导。</p> </div> </div> </div>, tagList=[TagDto(tagId=114674, tagName=射血分数降低心力衰竭)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=335, guiderKeyword=心力衰竭, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3314, appHits=407, showAppHits=0, pcHits=565, showPcHits=2907, likes=4, shares=57, comments=10, approvalStatus=1, publishedTime=Sat Sep 11 12:01:18 CST 2021, publishedTimeString=2021-08-27, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Sep 10 21:17:06 CST 2021, updatedBy=92910, updatedName=rayms, updatedTime=Fri Jan 05 10:25:48 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021心衰专家共识：优化射血分数降低心力衰竭改善预后的药物.pdf)])
2021心衰专家共识：优化射血分数降低心力衰竭改善预后的药物.pdf
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1198354, encodeId=e2721198354a3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=877f6487630, createdName=ms8000001376264333, createdTime=Tue Mar 01 13:52:01 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060060, encodeId=60b910600602f, content=是英文还是译文？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/f4d578d162014e7a9c97e64daca617d4/41f548c53a2b413292d0392cde1ff4ad.jpg, createdBy=0a872181743, createdName=不吃奶糖, createdTime=Wed Oct 13 10:17:54 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057211, encodeId=7e0c105e211d6, content=谢谢 学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 18:31:15 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016855, encodeId=d69910168552d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7222472719, createdName=ZGZgood, createdTime=Sun Sep 12 21:08:14 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016851, encodeId=8f66101685179, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32345590573, createdName=ms7000001872588852, createdTime=Sun Sep 12 20:34:46 CST 2021, time=2021-09-12, status=1, ipAttribution=)]
    2022-03-01 ms8000001376264333

    好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1198354, encodeId=e2721198354a3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=877f6487630, createdName=ms8000001376264333, createdTime=Tue Mar 01 13:52:01 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060060, encodeId=60b910600602f, content=是英文还是译文？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/f4d578d162014e7a9c97e64daca617d4/41f548c53a2b413292d0392cde1ff4ad.jpg, createdBy=0a872181743, createdName=不吃奶糖, createdTime=Wed Oct 13 10:17:54 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057211, encodeId=7e0c105e211d6, content=谢谢 学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 18:31:15 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016855, encodeId=d69910168552d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7222472719, createdName=ZGZgood, createdTime=Sun Sep 12 21:08:14 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016851, encodeId=8f66101685179, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32345590573, createdName=ms7000001872588852, createdTime=Sun Sep 12 20:34:46 CST 2021, time=2021-09-12, status=1, ipAttribution=)]
    2021-10-13 不吃奶糖

    是英文还是译文？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1198354, encodeId=e2721198354a3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=877f6487630, createdName=ms8000001376264333, createdTime=Tue Mar 01 13:52:01 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060060, encodeId=60b910600602f, content=是英文还是译文？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/f4d578d162014e7a9c97e64daca617d4/41f548c53a2b413292d0392cde1ff4ad.jpg, createdBy=0a872181743, createdName=不吃奶糖, createdTime=Wed Oct 13 10:17:54 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057211, encodeId=7e0c105e211d6, content=谢谢 学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 18:31:15 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016855, encodeId=d69910168552d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7222472719, createdName=ZGZgood, createdTime=Sun Sep 12 21:08:14 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016851, encodeId=8f66101685179, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32345590573, createdName=ms7000001872588852, createdTime=Sun Sep 12 20:34:46 CST 2021, time=2021-09-12, status=1, ipAttribution=)]
    2021-10-03 H8888888

    谢谢 学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1198354, encodeId=e2721198354a3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=877f6487630, createdName=ms8000001376264333, createdTime=Tue Mar 01 13:52:01 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060060, encodeId=60b910600602f, content=是英文还是译文？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/f4d578d162014e7a9c97e64daca617d4/41f548c53a2b413292d0392cde1ff4ad.jpg, createdBy=0a872181743, createdName=不吃奶糖, createdTime=Wed Oct 13 10:17:54 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057211, encodeId=7e0c105e211d6, content=谢谢 学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 18:31:15 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016855, encodeId=d69910168552d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7222472719, createdName=ZGZgood, createdTime=Sun Sep 12 21:08:14 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016851, encodeId=8f66101685179, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32345590573, createdName=ms7000001872588852, createdTime=Sun Sep 12 20:34:46 CST 2021, time=2021-09-12, status=1, ipAttribution=)]
    2021-09-12 ZGZgood

    学习了

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1198354, encodeId=e2721198354a3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=877f6487630, createdName=ms8000001376264333, createdTime=Tue Mar 01 13:52:01 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060060, encodeId=60b910600602f, content=是英文还是译文？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/f4d578d162014e7a9c97e64daca617d4/41f548c53a2b413292d0392cde1ff4ad.jpg, createdBy=0a872181743, createdName=不吃奶糖, createdTime=Wed Oct 13 10:17:54 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057211, encodeId=7e0c105e211d6, content=谢谢 学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 18:31:15 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016855, encodeId=d69910168552d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7222472719, createdName=ZGZgood, createdTime=Sun Sep 12 21:08:14 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016851, encodeId=8f66101685179, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32345590573, createdName=ms7000001872588852, createdTime=Sun Sep 12 20:34:46 CST 2021, time=2021-09-12, status=1, ipAttribution=)]
    2021-09-12 ms7000001872588852

    学习#学习#

    0

拓展阅读

2010 中华医学会 急性心力衰竭诊断和治疗指南

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2010-01-01

心脏再同步治疗慢性心力衰竭的建议（2009年修订版）

中华医学会心电生理和起搏分会 · 2010-02-25

加拿大心衰诊疗指南（2010更新）：少数民族人口，心脏衰竭和怀孕，疾病管理，和质量改进/保证方案心力衰竭

加拿大心血管学会(CCS,Canadian Cardiovascular Society) · 2010-04-01

2010HFSA 心力衰竭治疗指南

美国心衰学会(HFSA,HEART FAILURE SOCIETY OF AMERICA) · 2010-07-01

2011AHA/ACC 急性心力衰竭综合征：急诊科表现、治疗、处置的现状及预期目的--来自美国心脏病协会科学声明

美国心脏协会(AHA,American Heart Association) · 2011-04-14

2012AHA 科学声明：心力衰竭诊疗进展科学决策

美国心脏协会(AHA,American Heart Association) · 2012-03-05